SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock breaks above key resistance levels, fueling bullish sentiment among traders. The community is actively discussing potential price targets and the possibility of a gamma squeeze, while also weighing factors like upcoming delivery numbers and potential rate cuts. Some traders caution about the impact of Elon Musk's political involvement and the company's fundamentals.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to recent listings on major exchanges like Binance and Upbit, driving significant buying pressure. The community is focused on potential price targets and comparing it to similar projects, with many believing it's poised for further gains. Discussions also highlight its underlying technology and backing, suggesting long-term potential beyond short-term price movements.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities (ASST) is trending due to its reverse merger with Strive Enterprises, a move anticipated to trigger a short squeeze and a strategic pivot towards Bitcoin asset management. The community is focused on the high short interest, potential forced buy-ins, and the possibility of news regarding Bitcoin purchases. Discussions also involve the technical aspects of trading platforms updating post-merger and the implications of a new CUSIP number.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending due to growing excitement around its potential as the top meme coin on the Injective blockchain ($INJ.X), particularly with the anticipated benefits from Injective's growing ecosystem and upcoming ETFs; community members are highlighting its strong fundamentals, burned liquidity, unique NFT collection and engaged community, with many anticipating significant gains as Injective gains wider recognition.

Towns

TOWNS.X is trending amid community excitement and volatility, with some users suggesting it's primed for a run while others caution about potential dumps. The conversation includes references to other cryptocurrencies like AVNT.X and PUMP.X, with some users moving between them in pursuit of profits.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is gaining attention as Pineapple Financial's $100 million investment and planned staking spark bullish sentiment, with some anticipating a Solana-like surge. The community is actively discussing meme coins within the Injective ecosystem, particularly $NONJA.X, which is touted for its strong community and potential for high returns.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

Shares of GCTK are active amid discussions about the company's recent funding agreements and upcoming presentation at the Q3 Virtual Investor Summit, with traders pointing to the stock's low float and potential for significant price movement. Community members are weighing the implications of the new capital and its effect on upcoming milestones and potential for a short squeeze. The stock is also being compared to other high-momentum low float plays.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X Shares

Direxion Daily TSLA Bull 2X Shares

TSLL is trending as traders anticipate movement from TSLA's earnings report. The community is actively discussing potential gains and optimal strategies, with some pointing to technical indicators suggesting a bullish trend. There's also excitement around potential catalysts like the robotaxi launch and expansion into new markets.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

EOSE is trending as traders discuss its potential in the energy storage sector, particularly for data centers, and its possible role in the renewable energy transition. The company's financial health and potential for a short squeeze are also being debated by investors, along with the significance of its new software suite, DawnOS.

Alchemy Pay

Alchemy Pay is trending as the crypto community discusses its potential amid recent partnerships and regulatory approvals, including a new Arizona Money Transmitter License. Community members are actively debating price predictions, supply limits, and the impact of these developments on its future value. Discussions also mention Alchemy Pay's relationship with Ripple ($XRP.X) and the broader implications for global crypto payments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cabaletta Bio (CABA) Upgraded to Buy: Here's Why

Cabaletta Bio (CABA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cabaletta Bio shares hit their highest levels in nearly two months on Thursday following an announcement of crucial regulatory and clinical progress for its leading autoimmune therapy, rese-cel.CABA shares closed up 2.36% at $164.70 on Thursday.The company said it has expanded its RESET-Myositis trial with two new subtypes-specific patient cohorts containing approximately 15 patients each.&nbsp;The expansion followed the U.S. FDA's approval of RMAT designation for rese-cel, which shows its potential treatment for myositis in Americans who have few therapeutic options.The company plans to submit a Biologics License Application (BLA) for rese-cel in 2027 based on a registrational study design that follows FDA guidelines.&nbsp;The RESET clinical development program enrolled 44 patients and administered doses to 23 by May 9.The RESET trials for myositis, systemic autoimmune diseases, SLE/LN, and systemic sclerosis will reveal new clinical data during the EULAR 2025 Congress in June.&nbsp;Cabaletta intends to begin registrational discussions with the FDA regarding SLE and lupus nephritis during Q3 2025, followed by conversations about systemic sclerosis in Q4 2025.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 3,500% surge in 24-hour message volume.Some traders said they reached one of their target prices for CABA and have exited their positions but remain optimistic about a possible upward move tomorrow, keeping an eye out for re-entry opportunities.&nbsp;<stembedurl>https://stocktwits.com/Mr_Stochastic/message/614829609</stembedurl>Another user highlighted that after-hours trading already accounted for a third of the daily volume within the first hour, expressing bullish expectations for the stock to open higher and potentially reach $10 within six months.<stembedurl>https://stocktwits.com/alecsalaur198/message/614824832</stembedurl>The stock has declined 55% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cabaletta Bio Stock Surges To 2-Month High On Autoimmune Therapy Progress; Retail’s Pleased

The company announced the addition of two subtype-specific cohorts to its RESET-Myositis trial and received RMAT designation from the FDA for rese-cel.

Equity

Buy Rating Affirmed for Cabaletta Bio Amid Superior CD19 CAR T Therapy Efficacy in Autoimmune Disease Treatment

Wells Fargo analyst Derek Archila maintained a Buy rating on Cabaletta Bio (CABA Research Report) yesterday and set a price target of $20.00. Der...

Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake

Bloomberg / Contributor / Getty Images

 Key TakeawaysBillionaire Stanley Druckenmiller added more than three dozen new positions to his portfolio in the first quarter, including Apple, Reddit...

Citigroup Boosts Cabaletta Bio (NASDAQ:CABA) Price Target to $30.00

Cabaletta Bio (NASDAQ:CABA - Free Report) had its price objective lifted by Citigroup from $26.00 to $30.00 in a report published on Thursday morning, Benzinga reports. Citigroup currently has a buy...

Cabaletta Bio (NASDAQ:CABA) PT Raised to $30.00

Cabaletta Bio (NASDAQ:CABA - Get Free Report) had its target price raised by stock analysts at Citigroup from $26.00 to $30.00 in a research note issued to investors on Thursday, Benzinga reports...

Cabaletta Bio price target raised by $4 at Citi, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cabaletta Bio (CABA, $16.83) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that CABA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Cabaletta Bio (CABA, $17.04) Aroon Indicator entered a Downtrend on March 28, 2024.

Cabaletta Bio (CABA, $17.14) Aroon Indicator entered a Downtrend on March 27, 2024.

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

CABA
Cabaletta Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CABA News

CABA Cabaletta Bio Inc